相关实验视频

Updated: Jun 26, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

在铁灭症中解开ETC复合物I功能揭示了LKB1缺乏癌症的潜在铁灭症诱导治疗策略

Chao Mao¹, Guang Lei¹, Amber Horbath¹

¹Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

|May 17, 2024

概括

线粒体电子运输链复合物I抑制在铁灭调节中具有双重作用. 抑制复合物I可以使LKB1缺乏的癌细胞对铁亡产生敏感,从而提供了一种新的治疗策略.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
癌症研究癌症研究

背景情况:

线粒体电子运输链 (ETC) 在细胞过程中起着复杂的作用.
铁亡是一种受调节的细胞死亡形式,与包括癌症在内的各种疾病有关.
通过ETC成分影响铁亡的确切机制尚不完全理解.

研究的目的:

研究线粒体ETC复合体I在调节铁亡中的作用.
探索针对癌症治疗中的I复合体的治疗潜力,特别是在LKB1缺乏的瘤中.

主要方法:

药物抑制和遗传废除ETC复合物I的药物抑制和遗传废除.
对ubiquinol和ATP水平的评估.
激活AMP激活蛋白激酶 (AMPK) 的作用.
通过抑制谷氨过氧化酶4 (GPX4) 诱导铁亡的评估.
在体内研究使用LKB1缺乏瘤的小鼠模型.
与放射治疗 (RT) 的联合疗法.

主要成果:

复合I抑制降低了ubiquinol和ATP水平,激活AMPK.
AMPK激活对铁亡有抑制作用.
在LKB1-AMPK无活化的细胞或细胞中抑制复合I或复合I的基因切除使癌细胞对GPX4抑制诱导的铁亡敏感.
复合I抑制与放射治疗协同作用,诱导铁亡并抑制LKB1缺乏的小鼠模型中的瘤生长.

结论:

线粒体ETC复合体I在ferroptosis调节中具有多方面的作用.
针对复合物I可以克服LKB1缺陷癌症中对铁亡的抵抗力.
综合I抑制与放射治疗相结合,为LKB1缺乏瘤提供了一个有前途的诱导铁亡的治疗策略.

关键词:

这就是AMPKK.欧洲贸易委员会综合体I.一个LKB1一个LKB1 癌症治疗疗法癌症治疗铁性化 (ferroptosis) 是一种脂类过氧化过氧化线粒体中的线粒体.

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...